CN1245184C - 一种治疗失眠的中药制剂及其制备方法 - Google Patents
一种治疗失眠的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN1245184C CN1245184C CN 200310105399 CN200310105399A CN1245184C CN 1245184 C CN1245184 C CN 1245184C CN 200310105399 CN200310105399 CN 200310105399 CN 200310105399 A CN200310105399 A CN 200310105399A CN 1245184 C CN1245184 C CN 1245184C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- present
- filtrate
- insomnia
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010022437 insomnia Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 9
- 230000008569 process Effects 0.000 title description 5
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000008187 granular material Substances 0.000 claims abstract description 13
- 239000007924 injection Substances 0.000 claims abstract description 9
- 238000002347 injection Methods 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 239000006188 syrup Substances 0.000 claims abstract description 8
- 235000020357 syrup Nutrition 0.000 claims abstract description 8
- 239000003826 tablet Substances 0.000 claims abstract description 8
- 239000006187 pill Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 239000000706 filtrate Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 10
- 238000004064 recycling Methods 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 7
- -1 filtered Substances 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims 1
- 229940057948 magnesium stearate Drugs 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 230000002936 tranquilizing effect Effects 0.000 abstract description 5
- 235000017060 Arachis glabrata Nutrition 0.000 abstract 1
- 244000105624 Arachis hypogaea Species 0.000 abstract 1
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract 1
- 235000018262 Arachis monticola Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000020232 peanut Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 description 6
- 206010013954 Dysphoria Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000006196 drop Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000013016 learning Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 229940074869 marquis Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000019468 Iatrogenic Disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
例数 | 临床治愈 | 显效 | 有效 | 无效 | 显效率 | 总有效率 | |
治疗组对照组 | 2020 | 41 | 63 | 810 | 26 | 50%20% | 90%70% |
例数 | 临床治愈 | 显效 | 有效 | 无效 | 显效率 | 总有效率 | |
治疗组对照组 | 2020 | 21 | 105 | 78 | 16 | 60%30% | 95%70% |
症状 | 治疗组 | 对照组 | ||||||||||
例 | 愈 | 显 | 有 | 无 | 总有效率 | 例 | 愈 | 显 | 有 | 无 | 总有效率 | |
入睡困难唾而不沉晨醒过早多梦头晕耳鸣心悸汗出五心烦热口干咽燥腰膝酸软健忘 | 20191617161215161312 | 4634345632 | 7524456543 | 76107624453 | 2212310114 | 90.0%89.5%93.8%88.2%81.3%91.7%100.0%93.8%92.3%66.7% | 18191518141416131511 | 3122214320 | 4342354243 | 7948553552 | 4656435346 | 77.8%68.4%66.7%66.7%71.4%78.6%68.8%76.9%73.3%45.5% |
治疗前 | 治疗的 | ||||||
舌红少苔 | 舌红苔黄 | 其他 | 正常 | 舌红少苔 | 舌红苔黄 | 其他 | |
治疗组对照组 | 311 | 45 | 34 | 1410 | 25 | 22 | 23 |
治疗前 | 治疗的 | ||||||
细数 | 沉细 | 其他 | 正常 | 细数 | 沉细 | 其他 | |
治疗组对照组 | 1513 | 34 | 23 | 149 | 25 | 24 | 12 |
例数 | 停药 | 减量 | 不变 | 总全停减率 | |
治疗组对照组 | 1615 | 73 | 52 | 410 | 75%33.3% |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310105399 CN1245184C (zh) | 2003-11-07 | 2003-11-07 | 一种治疗失眠的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310105399 CN1245184C (zh) | 2003-11-07 | 2003-11-07 | 一种治疗失眠的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1541682A CN1541682A (zh) | 2004-11-03 |
CN1245184C true CN1245184C (zh) | 2006-03-15 |
Family
ID=34333727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310105399 Expired - Lifetime CN1245184C (zh) | 2003-11-07 | 2003-11-07 | 一种治疗失眠的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1245184C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727603A (zh) * | 2011-03-31 | 2012-10-17 | 上海兰蒂斯生物医药科技有限公司 | 一种口服制剂及其制备方法 |
CN103028036A (zh) * | 2011-12-06 | 2013-04-10 | 西安泰科迈医药科技有限公司 | 一种改善睡眠的胶囊及其制备方法 |
-
2003
- 2003-11-07 CN CN 200310105399 patent/CN1245184C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1541682A (zh) | 2004-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1723981A (zh) | 罗汉果提取物用于制备药物辅料的新用途 | |
CN104547826B (zh) | 高良姜提取物治疗痛经的医药用途 | |
US20110104290A1 (en) | Compositions for reducing blood glucose level and uses thereof | |
CN1857664A (zh) | 中风制剂及新的制备方法 | |
CN102319294A (zh) | 双香草制剂及其制备方法 | |
CN1895547A (zh) | 一种治疗糖尿病的药物及制备方法 | |
CN103181949A (zh) | 一种镇静安神口服制剂及其制备方法 | |
CN1927324A (zh) | 用于治疗妇女月经不调中药制剂的制备方法 | |
CN1814214A (zh) | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 | |
CN1245184C (zh) | 一种治疗失眠的中药制剂及其制备方法 | |
CN102743646B (zh) | 一种检验及预防糖尿病的药物组合物 | |
CN105456818A (zh) | 一种含有艾叶的治疗失眠的中药组合物及其制备方法 | |
CN102178792B (zh) | 一种石歧外感中药口含片 | |
CN102274394A (zh) | 一种治疗产后便秘的中药组合物 | |
CN104644734A (zh) | 一种治疗ⅱ型糖尿病及其并发症的药物 | |
CN110755601B (zh) | 一种治疗hiv/aids免疫重建缺陷的芸豆凝集素植物药组合物和制备方法及其应用 | |
CN104225425A (zh) | 一种提高免疫力、改善睡眠、预防心脑血管疾病的中药制剂及其制备方法 | |
CN105125885B (zh) | 一种用于防治糖尿病的中药组合物及其制备方法 | |
CN103301244B (zh) | 一种治疗小儿肺炎的中药制剂及其制备方法 | |
CN102949681B (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN100428942C (zh) | 一种养心安神药物及其制备方法 | |
CN1736434A (zh) | 甘草爽喉片的药物及其制备方法 | |
CN107802676B (zh) | 一种紫丁香提取物及其制备方法和应用 | |
CN104352672A (zh) | 一种含龟板的治疗糖尿病的中药组合物 | |
CN1306830A (zh) | 一种治疗ⅱ型糖尿病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG C.P. FREDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LING PEIXUE Effective date: 20091225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091225 Address after: Lunan Road, hi tech Zone, Shandong, Ji'nan Patentee after: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. Address before: No. 264, mountain road, Shandong, Ji'nan Patentee before: Ling Peixue |
|
C53 | Correction of patent of invention or patent application | ||
C56 | Change in the name or address of the patentee | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Ling Inventor after: Ling Peixue Inventor after: Yu Shengmao Inventor after: Shi Yanzeng Inventor after: Pang Xiaoyang Inventor after: Zhang Hui Inventor before: Zhang Ling Inventor before: Ling Peixue Inventor before: Hu Qingwen Inventor before: Yu Shengmao Inventor before: Shi Yanzeng Inventor before: Jing Rui Inventor before: Pang Xiaoyang Inventor before: Zhang Hui |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG LING LING PEIXUE HU QINGWEN YU SHENGMAO SHI YANZENG JING RUI PANG XIAOYANG ZHANG HUI TO: ZHANG LING LING PEIXUE YU SHENGMAO SHI YANZENG PANG XIAOYANG ZHANG HUI |
|
CP03 | Change of name, title or address |
Address after: Hi tech District Ji'nan city Shandong province 250104 Road No. 3333 Patentee after: SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co.,Ltd. Address before: 250104 Lunan Road, Ji'nan hi tech Zone, Shandong Patentee before: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PHARMACEUTICAL SCIENCES, SHANDONG PROVINCE Free format text: FORMER OWNER: SHANDONG MINGREN FREDA PHARMACEUTICAL CO., LTD. Effective date: 20150626 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150626 Address after: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Patentee after: SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES Address before: Hi tech District Ji'nan city Shandong province 250104 Road No. 3333 Patentee before: SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20060315 |
|
CX01 | Expiry of patent term |